8-K/A XBRL

FORM 8-K/A

Company: Barinthus Biotherapeutics plc.
Filed: May 24, 2022
Period of Report: May 12, 2022
Accession Number: 0001104659-22-064100

View Document ↗ View on SEC.gov ↗